Madura Biotech Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
- Paid Up Capital ₹ 2.73 Cr
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.54 M
- Revenue Growth 1714.60%
- Profit Growth 97.42%
- Ebitda 102.48%
- Net Worth -0.27%
- Total Assets 0.64%
About Madura Biotech
Madura Biotech Private Limited (MBPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 April 2008 and has a history of 16 years and nine months. Its registered office is in Delhi, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 2.73 Cr.
The company currently has active open charges totaling ₹2.54 M.
Jay Bhagwan and Radheshyam Meena serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U15411DL2008PTC177316
- Company No.
177316
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Madura Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jay Bhagwan  | Additional Director | 15-Nov-2022 | Current |
| Radheshyam Meena | Additional Director | 15-Dec-2022 | Current |
Financial Performance of Madura Biotech.
Madura Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1714.6% increase. The company also saw a substantial improvement in profitability, with a 97.42% increase in profit. The company's net worth dipped by a decrease of 0.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Madura Biotech?
In 2020, Madura Biotech had a promoter holding of 44.65% and a public holding of 55.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.25 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Feb 2015 | Bank Of Baroda | ₹0.94 M | Open |
| 08 Jun 2012 | Bank Of Baroda | ₹1.60 M | Open |
How Many Employees Work at Madura Biotech?
Unlock and access historical data on people associated with Madura Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Madura Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Madura Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
